A 15-day-old neonate is found on newborn screening to have elevated TSH (85 mIU/L) and low T4. The neonate appears comfortable but has prolonged jaundice, large fontanelle, constipation, and umbilical hernia. Treatment with levothyroxine is initiated. What is the TARGET TSH range and T4 range during the first 1–3 years of life in treated congenital hypothyroidism?
- A TSH <5 mIU/L; T4 within age-specific normal range
- B TSH 0.5–2.0 mIU/L; T4 upper half of the age-specific reference range ✓
- C TSH suppressed <0.1 mIU/L to ensure maximum thyroid hormone replacement
- D TSH 5–10 mIU/L is acceptable during the first year as the pituitary re-sets
Explanation
For optimal neurodevelopmental outcomes in congenital hypothyroidism, treatment targets during the critical brain development window (first 3 years) should keep TSH in the low-normal range of 0.5–2.0 mIU/L and T4 (free T4 or total T4) in the upper half of the age-specific reference range. Subnormal TSH suppression risks adverse effects on bone mineralization; persistently elevated TSH indicates under-treatment and threatens cognitive outcome. The starting dose of levothyroxine is 10–15 mcg/kg/day, and it must be started within 2 weeks of birth for best outcomes. Monitoring with TFTs at 2 weeks after initiation, then every 1–3 months in year 1.
Reference: Ghai Essential Pediatrics, 10th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.